Characterization of pregnant women with associated metabolic disorders

Authors

  • Nairovys Gómez Martínez
  • Franklin Andrés Núñez Cobos
  • Riber Fabián Donoso Noroña
  • Belkis Sánchez Martínez

Keywords:

Metabolic disorders, pregnant women, nursing, intervention, care

Abstract

Introduction: Metabolic disorders constitute a term used for metabolic and cardiovascular diseases associated with insulin resistance and abdominal obesity, which may be risky during pregnancy.
Objective: To characterize pregnant women with associated metabolic disorders.
Methods: It was a quantitative study with an epidemiological design in 68 pregnant women, corresponding to the descriptive level, supported by statistics to calculate the absolute and relative frequencies of the characterization variables studied, being observational, cross-sectional, descriptive, and retrospective. Results: The findings of this research determined that 36.76% of pregnant women suffered from overweight; 13.24% from obesity; and 7.35% of them were diagnosed with preeclampsia. Also, 66.18% did not engage in physical activity; 77.94% of pregnant women had high cholesterol levels; 2.94% had systolic hypertension; and 8.82% had alterations in glucose levels. It was evidenced that overweight had a close relationship with sedentary lifestyle, being the main condition found in pregnant women who were studied for presenting metabolic disorders.
Conclusions: It is concluded that, by creating a care plan, nurses can identify patients with metabolic disorders and start monitoring them to ensure adequate permanence of care and intervention. In addition, some future studies are proposed that may help health professionals to improve the care of pregnant women with associated metabolic disorders.

Downloads

Download data is not yet available.

Published

2023-07-02

How to Cite

1.
Gómez Martínez N, Núñez Cobos FA, Donoso Noroña RF, Sánchez Martínez B. Characterization of pregnant women with associated metabolic disorders. Rev Cubana Inv Bioméd [Internet]. 2023 Jul. 2 [cited 2025 Jul. 31];42(2). Available from: https://revibiomedica.sld.cu/index.php/ibi/article/view/2878